Filing Details

Accession Number:
0001209191-15-035062
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-17 17:33:04
Reporting Period:
2015-04-15
Filing Date:
2015-04-17
Accepted Time:
2015-04-17 17:33:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1123494 Harvard Bioscience Inc HBIO Laboratory Analytical Instruments (3826) 043306140
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008643 David Green 84 October Hill Road
Holliston MA 01746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-04-15 15,700 $6.53 798,553 No 4 S Direct
Common Stock Disposition 2015-04-16 21,303 $6.59 777,250 No 4 S Direct
Common Stock Disposition 2015-04-17 5,500 $6.49 771,750 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 322,124 Indirect David Green 2015-1 Annuity Trust
Common Stock 300,000 Indirect David Green 2013 Annuity Trust
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $6.45 to $6.59. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 722,563 shares of common stock held by the Reporting Person.
  3. This transaction was executed in multiple trades at prices ranging from $6.51 to $6.62. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 701,260 shares of common stock held by the Reporting Person.
  5. This transaction was executed in multiple trades at prices ranging from $6.38 to $6.60. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. Includes (a) a deferred stock award of 19,400 restricted stock units which vest on May 30, 2015; (b) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (c) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; and (d) 695,760 shares of common stock held by the Reporting Person.